DBV Technologies SA (DBVT)

16.00 -0.59 (-3.56%) USD  |  NASDAQ  |  Jun 08, 16:00
16.04 +0.04 (+0.25%) After-Hours: 20:00
More

DBV Technologies SG&A Expense (Quarterly) : 15.36M for March 31, 2026

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for DBVT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Cellectis SA 5.610M
Akari Therapeutics Plc 2.165M
Bicycle Therapeutics Plc 17.44M
Autolus Therapeutics Plc 39.89M
Evaxion AS 1.527M